ストックスクリーナーアプリを入手
13.13
7.01%
-0.99
アフターアワーズ：
13.13
前日終値:
$14.12
開ける：
$13.91
24時間の取引高:
1.48M
Relative Volume:
0.64
時価総額：
$895.35M
収益：
$2.66B
当期純損益:
$-1.21B
株価収益率:
-0.7368
EPS:
-17.82
ネットキャッシュフロー:
$-159.40M
1週間 パフォーマンス:
-2.74%
1か月 パフォーマンス:
+27.23%
6か月 パフォーマンス:
-55.32%
1年 パフォーマンス:
-53.16%
1日の値動き範囲:
$13.01
$14.36
1週間の範囲:
$12.87
$14.99
52週間の値動き範囲:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
名前
Quidelortho Corp
セクター
電話
(858) 552-1100
住所
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
13.13 | 993.54M | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-07 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-08 | アップグレード | Jefferies | Hold → Buy |
| 2024-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2024-12-10 | 開始されました | Jefferies | Hold |
| 2024-09-19 | 再開されました | UBS | Neutral |
| 2024-09-05 | アップグレード | Craig Hallum | Hold → Buy |
| 2024-03-04 | ダウングレード | UBS | Neutral → Sell |
| 2024-02-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-14 | アップグレード | UBS | Sell → Neutral |
| 2022-09-19 | 開始されました | Citigroup | Neutral |
| 2022-07-20 | 開始されました | UBS | Sell |
| 2022-06-17 | 再開されました | JP Morgan | Neutral |
| 2022-02-22 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-03-26 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2018-10-23 | 再開されました | Raymond James | Strong Buy |
| 2018-03-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-04 | アップグレード | CL King | Neutral → Buy |
| 2017-09-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | 繰り返されました | Canaccord Genuity | Hold |
| 2017-02-17 | 開始されました | CL King | Neutral |
| 2016-12-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | 繰り返されました | Barclays | Overweight |
| 2016-02-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-12-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | 開始されました | Barclays | Overweight |
| 2013-07-31 | 繰り返されました | Canaccord Genuity | Buy |
| 2011-03-03 | ダウングレード | Wedbush | Outperform → Neutral |
すべてを表示
Quidelortho Corp (QDEL) 最新ニュース
QuidelOrtho and Allo Hope Foundation partner to advance prenatal care for maternal alloimmunization - Select Science
Is the options market predicting a spike in QuidelOrtho stock? - MSN
QuidelOrtho (QDEL) up 24.1% since last earnings report: Can it continue? - MSN
Is the Options Market Predicting a Spike in QuidelOrtho Stock? - TradingView
QuidelOrtho (QDEL) director receives 1,183 shares from restricted stock unit release - Stock Titan
QuidelOrtho (QDEL) director settles 973 RSUs into common stock award - Stock Titan
QuidelOrtho (NASDAQ: QDEL) director gains 2,156 shares via RSU release - Stock Titan
QuidelOrtho Corp (QDEL) director gains 1,252 shares from RSU release - Stock Titan
QuidelOrtho CorporationCommon Stock (NQ: QDEL - FinancialContent
A Look At QuidelOrtho (QDEL) Valuation After Recent Share Price Rebound And Longer Term Weakness - Yahoo Finance
Assessing QuidelOrtho (QDEL) Valuation After A Sharp One Month Share Price Rebound - simplywall.st
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk - TradingView
QuidelOrtho Corporation (QDEL) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
QuidelOrtho Corp stock (US7476011036): partnership news and conference appearance in focus - AD HOC NEWS
QuidelOrtho (QDEL) director adds 6,829 shares via RSU vesting - Stock Titan
Director at QuidelOrtho (QDEL) gains 6,829 shares through RSU vesting - Stock Titan
QuidelOrtho (QDEL) director RSUs vest into 6,829 shares, holding 19,469 directly - Stock Titan
QuidelOrtho (QDEL) director adds 6,829 shares through RSU vesting - Stock Titan
QuidelOrtho (QDEL) director gains 6,829 shares as RSUs vest - Stock Titan
Director R. Scott Huennekens gains 6,829 QuidelOrtho (QDEL) shares via RSU vesting - Stock Titan
QuidelOrtho Corp (QDEL) director awarded 6,829 shares in equity grant - Stock Titan
QuidelOrtho (QDEL) director Ann D. Rhoads receives 6,829 shares as RSUs vest - Stock Titan
Director at QuidelOrtho (QDEL) gains 6,829 shares via RSU vesting - Stock Titan
QuidelOrtho (QDEL) director awarded 6,829 shares via RSU vesting - Stock Titan
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Educ - GuruFocus
QuidelOrtho Partners with Allo Hope Foundation for Early Pregnan - GuruFocus
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies - Barchart
McIntyre Partnerships’ Analysis on QuidelOrtho Corporation (QDEL) - Insider Monkey
QuidelOrtho Corp stock (US7476011036): shares volatile after Q1 2026 loss and outlook reset - AD HOC NEWS
QuidelOrtho (QDEL) reports Q1 loss, tops revenue estimates - MSN
QuidelOrtho Corp stock (US7476011036): director share purchase and CFO transition in focus - AD HOC NEWS
A Look at QuidelOrtho Corp (QDEL) After 6.0% Gain -- GF Value $3 - GuruFocus
Director at QuidelOrtho (QDEL) receives 1,407 shares from RSU release - Stock Titan
QuidelOrtho Q1 2026 Earnings: EPS Misses Estimates Sharply, Stock Declines 4.28%Fiscal Year Earnings - thelegaladvocate.com
QuidelOrtho Corp (QDEL) Stock Down 4.2% -- Now Undervalued? GF S - GuruFocus
How Quidelortho Corp Com (QDEL) Affects Rotational Strategy Timing - Stock Traders Daily
When Blood Compatibility Becomes a Pregnancy Risk – Company Announcement - Financial Times
QuidelOrtho stock (US7476011036): Shares rise after latest market move - AD HOC NEWS
When blood compatibility becomes a threat in pregnancy, and how tests help - Stock Titan
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences - Yahoo Finance
QuidelOrtho (QDEL) price target decreased by 34.46% to 19.25 - MSN
QuidelOrtho stock (US7476011036): Shares fall after recent after-hours pressure - AD HOC NEWS
QuidelOrtho Corp stock (US7476011036): analysts divided as short interest climbs and sentiment weake - AD HOC NEWS
5 Insightful Analyst Questions From QuidelOrtho’s Q1 Earnings Call - Yahoo Finance
QuidelOrtho Corp (QDEL) Shares Surge 3.0% -- What GF Score of 48 Tells Investors - GuruFocus
Quidelortho Corp (QDEL) 財務データ
収益
当期純利益
現金流量
EPS
Quidelortho Corp (QDEL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
2.43%
大文字化:
|
ボリューム (24 時間):